LpxC inhibitor (Blacksmith Medicines)

N/A

Report date: 2025/06/11 10:48:58
NME

Base Information

Drug NameLpxC inhibitor (Blacksmith Medicines)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitorsAntibacterial multidrug resistance inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsReproductive Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlacksmith Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlacksmith Medicines Inc
Inactive CompaniesN/A
Active IndicationsReproductive Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A